These notices may include a list of possible medication recalls, market withdrawals, alerts and warnings. According to the FDA, it could be dangerous for patients with this serious condition to stop taking their Metformin without first talking to their healthcare professionals. FDA is also collaborating with international regulators to share testing results for metformin, along with testing results for other drugs.FDA will continue to monitor NDMA in metformin, along with other drugs products, and will provide timely updates of new developments, including product recalls.
Select one or more newsletters to continue. It is packaged in a bottle containing 60 tablets with NDC 68180-336-07.
It could be dangerous for patients with type 2 diabetes to stop taking their metformin without first talking to their health care professional. You may report them to the The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Wockhardt announced a recall of 109,744 bottles of Metoprolol Succinate Extended-Release 50mg Tablets, the generic version of AstraZeneca's Toprol XL. FDA discovered chemical NDMA in extended-release metformin The recalled NDC’s are included in the table below:Metformin Hydrochloride Extended-Release Tablets USPLupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, drug chain, mail order pharmacies and supermarkets by phone and through recall notification and is arranging for the return of all the recalled product NDC’s.Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 1000mg, are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. Anyone with an existing inventory of the product should quarantine the recalled lots immediately.Customers who purchased the impacted product directly from Amneal may call Amneal at 1-833-582-0812 or email to Retailers who have Metformin Hydrochloride Extended Release Tablets, USP, 500 mg or 750 mg, which are being recalled, should cease dispensing and contact Inmar at 855-532-1851 or via email at If you would like to report any adverse reactions or quality problems experienced with the use of this product you may contact Amneal Drug Safety by phone at 1-877-835-5472, Monday - Friday, 8:00 am – 6:00 pm, EST, or via e-mail at Any adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.Certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the Private Securities Litigation Reform Act of 1995). On 7/22/2020, Granules Pharmaceuticals recalled Metformin ER due to the presence of an impurity. Apotex Corp has agreed to recall this lot, and out of an abundance of caution, the company is extending the recall to all lots of Metformin Hydrochloride Extended-Release Tablets in the US. Together, all Lupin-owned entities combine to make up the 8th largest generic pharmaceutical company in the world by revenue size.Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality medications across many treatment areas. Overall, FDA observed that in orthogonal tests, the levels of NDMA, when present, were generally lower than reported by the private laboratory.The paper provides additional details of FDA’s investigation and the importance of selection and validation of testing methods.In summary, the agency found the private laboratory method to be inappropriate for quantifying NDMA in metformin drug products due to presumptive overestimation of NDMA caused by the presence of a substance that interfered with the testing results.There are additional companies that manufacturer ER metformin and supply a significant portion of the U.S. market, whose products are not being recalled at this time.Patients taking recalled ER metformin should continue taking it until a doctor or pharmacist gives them a replacement or a different treatment option. In addition to metformin and the blood-pressure drugs, the FDA last month asked for a recall of all versions of Zantac, which is also sold … Metoprolol (Lopressor, Toprol XL) is a prescription drug used to treat high blood pressure, angina, abnormal rhythms of the heart, and some neurological conditions. Drug interactions, dosage, and pregnancy and breastfeeding safety information are provided. Side effects include low blood pressure, dreaming, diarrhea, abdominal cramps, and sore throat. Bayshore Pharmaceuticals, LLC is in the process of notifying its customers affected by this recall by phone and through recall notification and is arranging for return of the entire recalled product. It could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professionals.FDA plans to post the methods used in laboratory testing of metformin in the near future. They are mixed with inactive ingredients to produce finished pills.Millions of blood-pressure pills known as angiotensin II receptor blockers were recalled beginning in July 2018 after it was found their active ingredients were contaminated with NDMA as a byproduct of the manufacturing process.In addition to metformin and the blood-pressure drugs, the FDA last month asked for a recall of all versions of Zantac, which is also sold under the name ranitidine, after the agency determined that the chemical makeup of the stomach drug can cause NDMA to form and increase when stored at high temperatures.